{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:06:12Z","timestamp":1791237972528,"version":"4.1.0"},"reference-count":61,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Psoriasis is an inflammatory and auto-immune skin-disease characterized by uncontrolled keratinocyte proliferation. Its pathogenesis is not still fully understood; however, an aberrant and excessive inflammatory and immune response can contribute to its progression. Recently, more attention has been given to the anti-inflammatory and immunomodulators effects of melatonin in inflammatory diseases. The aim of this paper was to investigate the effect of melatonin on psoriatic phenotype and also in S. aureus infection-associated psoriasis, with an in vitro model using Skinethic Reconstructed Human Epidermis (RHE). An in vitro model was constructed using the RHE, a three-dimensional-model obtained from human primary-keratinocytes. RHE-cells were exposed to a mix of pro-inflammatory cytokines, to induce a psoriatic phenotype; cells were also infected with S. aureus to aggravate psoriasis disease, and then were treated with melatonin at the concentrations of 1 nM, 10 nM, and 50 nM. Our results demonstrated that melatonin at higher concentrations significantly reduced histological damage, compared to the cytokine and S. aureus groups. Additionally, the treatment with melatonin restored tight-junction expression and reduced pro-inflammatory cytokine levels, such as interleukin-1\u03b2 and interleukin-12. Our results suggest that melatonin could be considered a promising strategy for psoriasis-like skin inflammation, as well as complications of psoriasis, such as S. aureus infection.<\/jats:p>","DOI":"10.3390\/biomedicines10040752","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:20:25Z","timestamp":1648038025000},"page":"752","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of Melatonin on Psoriatic Phenotype in Human Reconstructed Skin Model"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-9739","authenticated-orcid":false,"given":"Sarah Adriana","family":"Scuderi","sequence":"first","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, 31-98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cucinotta","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, 31-98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Filippone","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, 31-98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Lanza","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, 31-98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Campolo","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, 31-98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Paterniti","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, 31-98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-6387","authenticated-orcid":false,"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D\u2019Alcontres, 31-98166 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.033217","article-title":"Psoriasis: Epidemiology, clinical features, and quality of life","volume":"64","author":"Langley","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","article-title":"Keratinocyte: A trigger or an executor of psoriasis?","volume":"108","author":"Ni","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/bjd.15366","article-title":"Risks for Staphylococcus aureus colonization in patients with psoriasis: A systematic review and meta-analysis","volume":"177","author":"Ng","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Filippone, A., Consoli, G., Granata, G., Casili, G., Lanza, M., Ardizzone, A., Cuzzocrea, S., Esposito, E., and Paterniti, I. (2020). Topical Delivery of Curcumin by Choline-Calix[4]arene-Based Nanohydrogel Improves Its Therapeutic Effect on a Psoriasis Mouse Model. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145053"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0019-5154.48977","article-title":"Current concepts in the pathogenesis of psoriasis","volume":"54","author":"Das","year":"2009","journal-title":"Indian J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A Critical Role of the IL-1\u03b2\u2013IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis","volume":"139","author":"Cai","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/exd.13676","article-title":"Inhibition of interleukin-12 and\/or interleukin-23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?","volume":"27","author":"Ergen","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of Psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_10","first-page":"97","article-title":"Current Developments in the Immunology of Psoriasis","volume":"93","author":"Kerstan","year":"2020","journal-title":"Yale J. Biol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/2475530318810851","article-title":"TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management","volume":"4","author":"Li","year":"2018","journal-title":"J. Psoriasis Psoriatic Arthritis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/08916934.2016.1166214","article-title":"New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis","volume":"49","author":"Karczewski","year":"2016","journal-title":"Autoimmunity"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-079X.1993.tb00498.x","article-title":"Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis","volume":"14","author":"Poeggeler","year":"1993","journal-title":"J. Pineal Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jpi.12137","article-title":"Melatonin, energy metabolism, and obesity: A review","volume":"56","author":"Amaral","year":"2014","journal-title":"J. Pineal Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-079X.2010.00796.x","article-title":"Melatonin reduces hyperalgesia associated with inflammation","volume":"49","author":"Esposito","year":"2010","journal-title":"J. Pineal Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/14737175.2016.1182020","article-title":"The antioxidative property of melatonin against brain ischemia","volume":"16","author":"Paterniti","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.-M. (2020). Melatonin\u2019s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10.","DOI":"10.3390\/biom10091211"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1007\/s12035-016-0131-9","article-title":"PPAR-\u03b1 Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury","volume":"54","author":"Paterniti","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.12-224691","article-title":"Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells","volume":"27","author":"Kim","year":"2013","journal-title":"FASEB J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1007\/s00018-017-2617-7","article-title":"Melatonin, mitochondria, and the skin","volume":"74","author":"Slominski","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/exd.13208","article-title":"Metabolism of melatonin in the skin: Why is it important?","volume":"26","author":"Slominski","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tem.2007.10.007","article-title":"Melatonin in the skin: Synthesis, metabolism and functions","volume":"19","author":"Slominski","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2014.07.024","article-title":"Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro","volume":"404","author":"Kim","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jid.2017.10.025","article-title":"Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions","volume":"138","author":"Slominski","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1749-6632.2000.tb05402.x","article-title":"Melatonin and Its Relation to the Immune System and Inflammation","volume":"917","author":"Reiter","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tiv.2018.01.008","article-title":"SkinEthic\u2122 RHE for in vitro evaluation of skin irritation of medical device extracts","volume":"50","author":"Pellevoisin","year":"2018","journal-title":"Toxicol. Vitr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sarkiri, M., Fox, S.C., Fratila-Apachitei, L.E., and Zadpoor, A.A. (2019). Bioengineered Skin Intended for Skin Disease Modeling. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061407"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2014.03.003","article-title":"An innovative three-dimensional model of normal human skin to study the proinflammatory psoriatic effects of tumor necrosis factor-alpha and interleukin-17","volume":"68","author":"Donetti","year":"2014","journal-title":"Cytokine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fbioe.2018.00154","article-title":"Advances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models","volume":"6","author":"Randall","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/1535370217710637","article-title":"In vitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research","volume":"242","author":"Desmet","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00403-013-1379-9","article-title":"Identifying targets for topical RNAi therapeutics in psoriasis: Assessment of a new in vitro psoriasis model","volume":"305","author":"Bracke","year":"2013","journal-title":"Arch Dermatol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1128\/IAI.72.10.5668-5675.2004","article-title":"Internalization of Staphylococcus aureus by Human Keratinocytes","volume":"72","author":"Kintarak","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Scuderi, S., Casili, G., Ardizzone, A., Forte, S., Colarossi, L., Sava, S., Paterniti, I., Esposito, E., Cuzzocrea, S., and Campolo, M. (2021). KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation. Cancers, 13.","DOI":"10.3390\/cancers13143444"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Casili, G., Lanza, M., Scuderi, S.A., Messina, S., Paterniti, I., Campolo, M., and Esposito, E. (2020). The Inhibition of Prolyl Oligopeptidase as New Target to Counteract Chronic Venous Insufficiency: Findings in a Mouse Model. Biomedicines, 8.","DOI":"10.3390\/biomedicines8120604"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lanza, M., Filippone, A., Ardizzone, A., Casili, G., Paterniti, I., Esposito, E., and Campolo, M. (2021). SCFA Treatment Alleviates Pathological Signs of Migraine and Related Intestinal Alterations in a Mouse Model of NTG-Induced Migraine. Cells, 10.","DOI":"10.3390\/cells10102756"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e00380-18","DOI":"10.1128\/AEM.00380-18","article-title":"A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice","volume":"84","author":"Wang","year":"2018","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41598-017-00087-x","article-title":"The combination of three-dimensional and rotary cell culture system promotes the proliferation and maintains the differentiation potential of rat BMSCs","volume":"7","author":"Tang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhang, X., Yin, M., and Zhang, L.-J. (2019). Keratin 6, 16 and 17\u2014Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis. Cells, 8.","DOI":"10.3390\/cells8080807"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.jidsymp.5650010","article-title":"Lessons Learned from Psoriatic Plaques Concerning Mechanisms of Tissue Repair, Remodeling, and Inflammation","volume":"11","author":"Nickoloff","year":"2006","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/archderm.1988.01670120027005","article-title":"Interleukin 2 and Psoriasis","volume":"124","author":"Lee","year":"1988","journal-title":"Arch. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.4049\/jimmunol.177.7.4917","article-title":"An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12\/IL-23 in Psoriasis","volume":"177","author":"Toichi","year":"2006","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0366-6999.221269","article-title":"Skin Microbiome: An Actor in the Pathogenesis of Psoriasis","volume":"131","author":"Wang","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3389\/fimmu.2019.01764","article-title":"Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders","volume":"10","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/561018","article-title":"Mechanisms of Action of Topical Corticosteroids in Psoriasis","volume":"2012","author":"Uva","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4161\/derm.17534","article-title":"Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going?","volume":"3","author":"Reichrath","year":"2011","journal-title":"Dermato-Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/cpr.12119","article-title":"Immunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cells","volume":"47","author":"Plaimee","year":"2014","journal-title":"Cell Prolif."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/ENDO:27:2:137","article-title":"On the Role of Melatonin in Skin Physiology and Pathology","volume":"27","author":"Slominski","year":"2005","journal-title":"Endocrine"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Rusanova, I., Mart\u00ednez-Ruiz, L., Florido, J., Rodr\u00edguez-Santana, C., Guerra-Librero, A., Acu\u00f1a-Castroviejo, D., and Escames, G. (2019). Protective Effects of Melatonin on the Skin: Future Perspectives. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194948"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Jaworek, A.K., Szepietowski, J.C., Ha\u0142ubiec, P., Wojas-Pelc, A., and Jaworek, J. (2021). Melatonin as an Antioxidant and Immunomodulator in Atopic Dermatitis\u2014A New Look on an Old Story: A Review. Antioxidants, 10.","DOI":"10.20944\/preprints202106.0581.v1"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/pai.12978","article-title":"The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double-blinded, placebo-controlled trial","volume":"29","author":"Ardakani","year":"2018","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-079X.2009.00718.x","article-title":"Melatonin inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"47","author":"Kim","year":"2009","journal-title":"J. Pineal Res."},{"key":"ref_54","first-page":"59","article-title":"The therapeutic activity of melatonin and its effect on immunological parameters of patients with eczema","volume":"66","author":"Arushanian","year":"2003","journal-title":"Eksp. Naia Klin. Farmakol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_56","unstructured":"Farci, F., and Mahabal, G.D. (2021). Hyperkeratosis, StatPearls."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/PTT.S64950","article-title":"Current knowledge on psoriasis and autoimmune diseases","volume":"6","author":"McCormick","year":"2016","journal-title":"Psoriasis Targets Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40246-018-0158-2","article-title":"Mutational analysis of epidermal and hyperproliferative type I keratins in mild and moderate psoriasis vulgaris patients: A possible role in the pathogenesis of psoriasis along with disease severity","volume":"12","author":"Elango","year":"2018","journal-title":"Hum. Genom."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Orsmond, A., Bereza-Malcolm, L., Lynch, T., March, L., and Xue, M. (2021). Skin Barrier Dysregulation in Psoriasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910841"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e1341969","DOI":"10.1080\/21688370.2017.1341969","article-title":"Scaffolding proteins in the development and maintenance of the epidermal permeability barrier","volume":"5","author":"Crawford","year":"2017","journal-title":"Tissue Barriers"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00136-8","article-title":"Keratinocytes and cytokines","volume":"88","year":"2002","journal-title":"Vet.-Immunol. Immunopathol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/4\/752\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:41:40Z","timestamp":1760136100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/4\/752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["biomedicines10040752"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10040752","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]}}}